Clinical Correlations between Treatment with Anticoagulants/Antiaggregants and Late Rectal Toxicity after Radiotherapy for Prostate Cancer

被引：1
|
作者：
Takeda, Ken [1 ]
Ogawa, Yoshihiro [1 ]
Ariga, Hisanori [1 ]
Koto, Masashi [1 ]
Sakayauchi, Toru [1 ]
Fujimoto, Keisuke [1 ]
Narazaki, Kakutaro [1 ]
Mitsuya, Masatoshi [1 ]
Takai, Yoshihiro [2 ]
Yamada, Shogo [1 ]
机构：
[1] Tohoku Univ, Sch Med, Dept Radiat Oncol, Aoba Ku, Sendaishi 9808574, Japan
[2] Tohoku Univ, Sch Med, Dept Radiol Sci, Aoba Ku, Sendaishi 9808574, Japan
来源：
ANTICANCER RESEARCH | 2009年 / 29卷 / 05期
关键词：
Prostate cancer; radiotherapy; late toxicity; rectal toxicity; EXTERNAL-BEAM IRRADIATION; TERM TREATMENT SEQUELAE; CONFORMAL RADIOTHERAPY; ADENOCARCINOMA; MULTICENTER; PREDICTORS; CARCINOMA; 3D-CRT; RTOG;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: To assess variables related to grade 2 or higher late rectal toxicity (LRT) in prostate cancer treated with external radiotherapy. Patients and Methods: A retrospective analysis was carried out of 232 patients with T1-T3 prostate cancer treated with 3-dimensional conformal radiotherapy (3DCRT) (106 patients) or intensity modulated radiotherapy (IMRT) (126 patients) between June 2000 and May 2007. One hundred and seventy-seven patients received androgen deprivation therapy (ADT);fifty patients used anticoagulants/antiaggregants for vascular disease. Results: The median follow-up was 31 months (range, 6-79). At 5 years, the cumulative incidence of grade 2 or 3 LRT was 5.6%. On multivariate analysis, medication with anticoagulants/antiaggregants was correlated with grade 2 or 3 LRT (p=0.027), whereas age, National Comprehensive Cancer Network risk group classification, use of ADT, radiotherapy technique (3DCRT vs. IMRT) and total irradiated dose were not. Conclusion: Treatment with anticoagulants/antiaggregants appears to be a factor in grade 2 or 3 LRT.
引用
收藏
页码：1831 / 1834
页数：4
相关论文
共 50 条
  • [1] Early Proctoscopy is a Surrogate Endpoint of Late Rectal Toxicity in Prostate Cancer Treated With Radiotherapy
    Ippolito, Edy
    Massaccesi, Mariangela
    Digesu, Cinzia
    Deodato, Francesco
    Macchia, Gabriella
    Pirozzi, Giuseppe Antonio
    Cilla, Savino
    Cuscuna, Daniele
    Di Lallo, Alessandra
    Mattiucci, Gian Carlo
    Mantini, Giovanna
    Pacelli, Fabio
    Valentini, Vincenzo
    Cellini, Numa
    Ingrosso, Marcello
    Morganti, Alessio Giuseppe
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : E191 - E195
  • [2] Time course of late rectal toxicity after radiation therapy for prostate cancer
    Odrazka, K.
    Dolezel, M.
    Vanasek, J.
    Vaculikova, M.
    Zouhar, M.
    Sefrova, J.
    Paluska, P.
    Vosmik, M.
    Kohlova, T.
    Kolarova, I.
    Macingova, Z.
    Navratil, P.
    Brodak, M.
    Prosvic, P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 138 - 143
  • [3] Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer
    Peeters, STH
    Lebesque, JV
    Heemsbergen, WD
    van Putten, WLJ
    Slot, A
    Dielwart, MFH
    Koper, PCM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1151 - 1161
  • [4] Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment
    Faria, Sergio L.
    Souhami, Luis
    Joshua, Bosede
    Vuong, Te
    Freeman, Carolyn R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 777 - 781
  • [5] Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer
    Rancati, Tiziana
    Fiorino, Claudio
    Fellin, Gianni
    Vavassori, Vittorio
    Cagna, Emanuela
    Borca, Valeria Casanova
    Girelli, Giuseppe
    Menegotti, Loris
    Monti, Angelo Filippo
    Tortoreto, Francesca
    Delle Canne, Stefania
    Valdagni, Riccardo
    RADIOTHERAPY AND ONCOLOGY, 2011, 100 (01) : 124 - 130
  • [6] Searching for Optimal Dose-Volume Constraints to Reduce Rectal Toxicity after Hypofractionated Radiotherapy for Prostate Cancer
    Faria, S.
    Joshua, B.
    Patrocinio, H.
    Dal Pra, A.
    Cury, F.
    Velly, A. M.
    Souhami, L.
    CLINICAL ONCOLOGY, 2010, 22 (10) : 810 - 817
  • [7] Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer
    Huang, EH
    Pollack, A
    Levy, L
    Starkschall, G
    Dong, L
    Rosen, I
    Kuban, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05): : 1314 - 1321
  • [8] Nomograms to predict late urinary toxicity after prostate cancer radiotherapy
    Mathieu, Romain
    Ospina Arango, Juan David
    Beckendorf, Veronique
    Delobel, Jean-Bernard
    Messai, Taha
    Chira, Ciprian
    Bossi, Alberto
    Prise, Elisabeth Le
    Guerif, Stephane
    Simon, Jean-Marc
    Dubray, Bernard
    Zhu, Jian
    Lagrange, Jean-Leon
    Pommier, Pascal
    Gnep, Khemara
    Acosta, Oscar
    De Crevoisier, Renaud
    WORLD JOURNAL OF UROLOGY, 2014, 32 (03) : 743 - 751
  • [9] Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397)
    Buettner, Florian
    Gulliford, Sarah L.
    Webb, Steve
    Sydes, Matthew R.
    Dearnaley, David P.
    Partridge, Mike
    PHYSICS IN MEDICINE AND BIOLOGY, 2009, 54 (21) : 6535 - 6548
  • [10] Factors Predicting Late Rectal Disorders after Radiation Therapy for Prostate Cancer
    Maebayashi, Toshiya
    Ishibashi, Naoya
    Aizawa, Takuya
    Sakaguchi, Masakuni
    Sato, Hideki
    Sato, Katsuhiko
    Matsui, Tsuyoshi
    Yamaguchi, Kenya
    Takahashi, Satoru
    CHINESE MEDICAL JOURNAL, 2017, 130 (20) : 2441 - 2446
12345